PEANUT ALLERGY
Clinical trials for PEANUT ALLERGY explained in plain language.
Never miss a new study
Get alerted when new PEANUT ALLERGY trials appear
Sign up with your email to follow new studies for PEANUT ALLERGY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New shot could help peanut allergy sufferers tolerate nuts
Disease control Recruiting nowThis study tests a new treatment called UKK-0018 for adults with peanut allergies. The treatment is given as a shot and aims to train the immune system to handle peanut exposure without severe reactions. The study involves 40 adults aged 18-55 and focuses on safety and whether it…
Matched conditions: PEANUT ALLERGY
Phase: PHASE1, PHASE2 • Sponsor: Ukko Inc • Aim: Disease control
Last updated May 14, 2026 12:05 UTC
-
Peanut patch for toddlers: a safer way to fight allergies?
Disease control Recruiting nowThis study tests a skin patch (DBV712) to see if it is safe for children aged 1 to 3 with peanut allergy. About 480 toddlers will wear the patch daily for 6 months. The goal is to check for side effects, not to cure the allergy, but to help control it.
Matched conditions: PEANUT ALLERGY
Phase: PHASE3 • Sponsor: DBV Technologies • Aim: Disease control
Last updated May 13, 2026 16:03 UTC
-
New food allergy treatment aims to cut reaction risks
Disease control Recruiting nowThis study tests modified oral immunotherapy (OIT) protocols for peanut, milk, and egg allergies in 360 participants. The goal is to see if using lower doses or processed allergens can reduce allergic reactions during treatment while still helping patients become desensitized to …
Matched conditions: PEANUT ALLERGY
Phase: NA • Sponsor: McGill University Health Centre/Research Institute of the McGill University Health Centre • Aim: Disease control
Last updated May 13, 2026 15:59 UTC
-
New peanut allergy treatment aims to help people tolerate peanuts
Disease control Recruiting nowThis study tests an experimental treatment called ENP-501 for people with peanut allergy. The goal is to see if it is safe and helps people eat more peanut without having an allergic reaction. About 68 people aged 14 to 50 will take part, including some without peanut allergy. Th…
Matched conditions: PEANUT ALLERGY
Phase: PHASE1, PHASE2 • Sponsor: N-Fold, LLC • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
Peanut patch hope: kids get continued allergy treatment
Disease control AVAILABLEThis program offers a peanut protein patch (Viaskin) to children aged 2 and older who have peanut allergies and were in a previous DBV712 study. The goal is to keep desensitizing them to peanuts, reducing the risk of severe reactions. Participants wear the patch daily, and it is …
Matched conditions: PEANUT ALLERGY
Sponsor: DBV Technologies • Aim: Disease control
Last updated May 06, 2026 16:02 UTC